Microcirculation (New York, N.Y. : 1994) · 2026
Impact of Androgen Deprivation Therapy on Choroidal Microcirculation Assessed Using Laser Speckle Flowgraphy.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Hashimoto Ryuya, Oka Ryo, Fujioka Naoki, Tanaka Kazufumi, Nunose Moe, Imai Sara, Takenaka Ryota, Noro Takahide, Somoto Takatoshi, Utsumi Takanobu, Kamiya Naoto, Yagi Fumihiko, Suzuki Hiroyoshi
Аннотация
OBJECTIVE: To determine whether androgen deprivation therapy (ADT) alters laser speckle flowgraphy (LSFG)-detectable choroidal microvascular dynamics: mean blur rate (MBR, blood flow) and beat strength over MBR (BOM, microvascular resistance). We also investigated whether such changes emerge even when cardio-ankle vascular index (CAVI)-assessed large-artery stiffness remains unchanged.
METHODS: This study included 17 right eyes of 17 men with prostate cancer. Serum testosterone, CAVI, and choroidal parameters (MBR, BOM) were obtained at baseline and 6 months post-ADT. Central choroidal thickness (CCT) and ocular perfusion pressure (OPP) were also recorded.
RESULTS: Serum testosterone significantly decreased (4.45 ± 1.96 to 0.20 ± 0.08 ng/mL; p < 0.001) after 6 months. Choroidal BOM increased significantly (0.94 ± 0.31 to 1.11 ± 0.31; p = 0.028), whereas CAVI (10.70 ± 1.28 to 10.68 ± 1.19), choroidal MBR (8.46 ± 4.50 to 7.89 ± 3.48), CCT, and OPP did not change significantly.
CONCLUSION: Choroidal BOM increased significantly during the initial 6 months of ADT, indicating higher microvascular resistance despite stable choroidal blood flow and unchanged large artery stiffness. This supports a "microcirculation-first" model. LSFG-derived BOM may serve as a biomarker for early detection and monitoring of microcirculatory dysfunction under systemic testosterone suppression.
METHODS: This study included 17 right eyes of 17 men with prostate cancer. Serum testosterone, CAVI, and choroidal parameters (MBR, BOM) were obtained at baseline and 6 months post-ADT. Central choroidal thickness (CCT) and ocular perfusion pressure (OPP) were also recorded.
RESULTS: Serum testosterone significantly decreased (4.45 ± 1.96 to 0.20 ± 0.08 ng/mL; p < 0.001) after 6 months. Choroidal BOM increased significantly (0.94 ± 0.31 to 1.11 ± 0.31; p = 0.028), whereas CAVI (10.70 ± 1.28 to 10.68 ± 1.19), choroidal MBR (8.46 ± 4.50 to 7.89 ± 3.48), CCT, and OPP did not change significantly.
CONCLUSION: Choroidal BOM increased significantly during the initial 6 months of ADT, indicating higher microvascular resistance despite stable choroidal blood flow and unchanged large artery stiffness. This supports a "microcirculation-first" model. LSFG-derived BOM may serve as a biomarker for early detection and monitoring of microcirculatory dysfunction under systemic testosterone suppression.